Symbicort pMDI with spacer device + Symbicort pMDI without spacer device
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Study is Being Conducted in Healthy Volunteers
Conditions
Study is Being Conducted in Healthy Volunteers
Trial Timeline
Nov 4, 2016 → Mar 27, 2017
NCT ID
NCT02934607About Symbicort pMDI with spacer device + Symbicort pMDI without spacer device
Symbicort pMDI with spacer device + Symbicort pMDI without spacer device is a phase 1 stage product being developed by AstraZeneca for Study is Being Conducted in Healthy Volunteers. The current trial status is completed. This product is registered under clinical trial identifier NCT02934607. Target conditions include Study is Being Conducted in Healthy Volunteers.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02934607 | Phase 1 | Completed |
Competing Products
20 competing products in Study is Being Conducted in Healthy Volunteers